186 related articles for article (PubMed ID: 15090466)
1. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q
Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433
[TBL] [Abstract][Full Text] [Related]
5. Reduced DNA repair capacity in lung cancer patients.
Wei Q; Cheng L; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
[TBL] [Abstract][Full Text] [Related]
6. Reduced DNA repair capacity in head and neck cancer patients.
Cheng L; Eicher SA; Guo Z; Hong WK; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):465-8. PubMed ID: 9641488
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma.
Dybdahl M; Vogel U; Frentz G; Wallin H; Nexø BA
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):77-81. PubMed ID: 9950243
[TBL] [Abstract][Full Text] [Related]
8. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes.
Pastorelli R; Cerri A; Mezzetti M; Consonni E; Airoldi L
Int J Cancer; 2002 Jul; 100(1):9-13. PubMed ID: 12115580
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
10. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
11. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype.
Seker H; Butkiewicz D; Bowman ED; Rusin M; Hedayati M; Grossman L; Harris CC
Cancer Res; 2001 Oct; 61(20):7430-4. PubMed ID: 11606376
[TBL] [Abstract][Full Text] [Related]
13. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes.
Qiao Y; Spitz MR; Shen H; Guo Z; Shete S; Hedayati M; Grossman L; Mohrenweiser H; Wei Q
Carcinogenesis; 2002 Feb; 23(2):295-9. PubMed ID: 11872635
[TBL] [Abstract][Full Text] [Related]
14. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ
Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380
[TBL] [Abstract][Full Text] [Related]
15. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
16. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
[TBL] [Abstract][Full Text] [Related]
17. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
[TBL] [Abstract][Full Text] [Related]
18. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
19. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
20. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
